Alpha DNA Investment Management’s Sixth Street Specialty TSLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-25,944
Closed -$556K – 244
2024
Q1
$556K Buy
25,944
+1,041
+4% +$22.4K 0.21% 113
2023
Q4
$538K Sell
24,903
-2,723
-10% -$55.9K 0.21% 103
2023
Q3
$565K Sell
27,626
-11,435
-29% -$228K 0.23% 106
2023
Q2
$730K Buy
+39,061
New +$712K 0.24% 129
2023
Q1
– Sell
-57,743
Closed -$1.03M – 205
2022
Q4
$1.03M Buy
+57,743
New +$1.04M 0.36% 121
2021
Q1
– Sell
-169
Closed -$3K – 779
2020
Q4
$3K Buy
+169
New +$3.21K ﹤0.01% 427

Other funds holding TSLX

Alpha DNA Investment Management's TSLX Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Sixth Street Specialty (TSLX) in Q2 2024, closing a stake of 25,944 shares — an estimated $556K sold.

Alpha DNA Investment Management first reported a position in TSLX in Q4 2020 and held it in 6 quarters. The position peaked at $1.03M in Q4 2022. 224 funds tracked by Wall St. Rank hold TSLX as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Sixth Street Specialty position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 25,944 Sixth Street Specialty shares in Q2 2024, an estimated $556K.
  • Alpha DNA Investment Management first reported a position in Sixth Street Specialty in Q4 2020 and held it in 6 quarters.
  • Alpha DNA Investment Management's Sixth Street Specialty position peaked at $1.03M in Q4 2022.
  • 224 funds tracked by Wall St. Rank held Sixth Street Specialty as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.